Structure

Physi-Chem Properties

Molecular Weight:  596.17
Volume:  546.164
LogP:  0.303
LogD:  0.035
LogS:  -4.399
# Rotatable Bonds:  8
TPSA:  216.2
# H-Bond Aceptor:  15
# H-Bond Donor:  6
# Rings:  5
# Heavy Atoms:  15

MedChem Properties

QED Drug-Likeness Score:  0.165
Synthetic Accessibility Score:  4.622
Fsp3:  0.519
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.218
MDCK Permeability:  4.332192838774063e-05
Pgp-inhibitor:  0.007
Pgp-substrate:  0.998
Human Intestinal Absorption (HIA):  0.736
20% Bioavailability (F20%):  0.001
30% Bioavailability (F30%):  0.959

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.191
Plasma Protein Binding (PPB):  63.59637451171875%
Volume Distribution (VD):  0.698
Pgp-substrate:  23.345523834228516%

ADMET: Metabolism

CYP1A2-inhibitor:  0.025
CYP1A2-substrate:  0.976
CYP2C19-inhibitor:  0.02
CYP2C19-substrate:  0.735
CYP2C9-inhibitor:  0.003
CYP2C9-substrate:  0.149
CYP2D6-inhibitor:  0.012
CYP2D6-substrate:  0.316
CYP3A4-inhibitor:  0.007
CYP3A4-substrate:  0.017

ADMET: Excretion

Clearance (CL):  1.444
Half-life (T1/2):  0.514

ADMET: Toxicity

hERG Blockers:  0.377
Human Hepatotoxicity (H-HT):  0.371
Drug-inuced Liver Injury (DILI):  0.967
AMES Toxicity:  0.752
Rat Oral Acute Toxicity:  0.013
Maximum Recommended Daily Dose:  0.008
Skin Sensitization:  0.19
Carcinogencity:  0.257
Eye Corrosion:  0.003
Eye Irritation:  0.022
Respiratory Toxicity:  0.03

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC293004

Natural Product ID:  NPC293004
Common Name*:   1-O-[Beta-D-Xylopyranosyl-(1->6)-Beta-D-Glucopyranosyl]-3,5,8-Trimethoxyxanthone
IUPAC Name:   3,5,8-trimethoxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyxanthen-9-one
Synonyms:  
Standard InCHIKey:  ZGNFNPROZXLZQC-IJEUNHHQSA-N
Standard InCHI:  InChI=1S/C27H32O15/c1-35-10-6-14-17(21(31)18-12(36-2)4-5-13(37-3)25(18)40-14)15(7-10)41-27-24(34)22(32)20(30)16(42-27)9-39-26-23(33)19(29)11(28)8-38-26/h4-7,11,16,19-20,22-24,26-30,32-34H,8-9H2,1-3H3/t11-,16-,19+,20-,22+,23-,24-,26+,27-/m1/s1
SMILES:  COc1cc2c(c(c1)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]3[C@@H]([C@H]([C@@H](CO3)O)O)O)O1)O)O)O)c(=O)c1c(ccc(c1o2)OC)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2409390
PubChem CID:   71747860
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9824 Swertia kouitchensis Species Gentianaceae Eukaryota n.a. n.a. n.a. PMID[23805995]
NPO9824 Swertia kouitchensis Species Gentianaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO9824 Swertia kouitchensis Species Gentianaceae Eukaryota n.a. n.a. n.a. Database[TCMID]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified IC50 = 360000.0 nM PMID[495915]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC293004 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9875 High Similarity NPC52353
0.9875 High Similarity NPC194483
0.9815 High Similarity NPC102028
0.9814 High Similarity NPC267254
0.9814 High Similarity NPC475155
0.9812 High Similarity NPC61791
0.9753 High Similarity NPC51774
0.9753 High Similarity NPC239549
0.9753 High Similarity NPC236191
0.9695 High Similarity NPC475261
0.9693 High Similarity NPC142996
0.9691 High Similarity NPC301683
0.9691 High Similarity NPC156977
0.9689 High Similarity NPC472383
0.9689 High Similarity NPC472381
0.9689 High Similarity NPC293629
0.9636 High Similarity NPC473895
0.9632 High Similarity NPC204693
0.963 High Similarity NPC183357
0.963 High Similarity NPC44328
0.963 High Similarity NPC22195
0.963 High Similarity NPC21190
0.963 High Similarity NPC105095
0.963 High Similarity NPC44558
0.963 High Similarity NPC79056
0.963 High Similarity NPC177731
0.9627 High Similarity NPC93099
0.9627 High Similarity NPC135345
0.9625 High Similarity NPC284277
0.9625 High Similarity NPC475366
0.9625 High Similarity NPC475497
0.9571 High Similarity NPC472386
0.9568 High Similarity NPC95855
0.9568 High Similarity NPC170675
0.9568 High Similarity NPC43587
0.9568 High Similarity NPC210042
0.9568 High Similarity NPC471457
0.9568 High Similarity NPC112755
0.9565 High Similarity NPC70441
0.9521 High Similarity NPC473883
0.9509 High Similarity NPC34287
0.9509 High Similarity NPC471416
0.9509 High Similarity NPC474434
0.9509 High Similarity NPC105511
0.9503 High Similarity NPC15358
0.9458 High Similarity NPC472387
0.9451 High Similarity NPC3583
0.9451 High Similarity NPC307518
0.9451 High Similarity NPC259152
0.9451 High Similarity NPC48773
0.9451 High Similarity NPC205076
0.9448 High Similarity NPC226294
0.9448 High Similarity NPC229687
0.9448 High Similarity NPC58053
0.9448 High Similarity NPC186807
0.9448 High Similarity NPC475942
0.9448 High Similarity NPC105025
0.9448 High Similarity NPC105283
0.9448 High Similarity NPC183036
0.9448 High Similarity NPC469931
0.9448 High Similarity NPC195257
0.9448 High Similarity NPC45638
0.9448 High Similarity NPC201292
0.9448 High Similarity NPC209296
0.9448 High Similarity NPC93337
0.9444 High Similarity NPC236934
0.9444 High Similarity NPC5778
0.9437 High Similarity NPC182045
0.9401 High Similarity NPC110941
0.9401 High Similarity NPC473682
0.9401 High Similarity NPC470443
0.9401 High Similarity NPC470444
0.9401 High Similarity NPC126784
0.9401 High Similarity NPC241423
0.9401 High Similarity NPC473571
0.9398 High Similarity NPC472380
0.9398 High Similarity NPC472382
0.9398 High Similarity NPC472384
0.9398 High Similarity NPC169733
0.9394 High Similarity NPC208668
0.939 High Similarity NPC231194
0.939 High Similarity NPC51326
0.939 High Similarity NPC210808
0.939 High Similarity NPC199079
0.939 High Similarity NPC224462
0.9387 High Similarity NPC45400
0.9387 High Similarity NPC146792
0.9387 High Similarity NPC58716
0.9387 High Similarity NPC45618
0.9375 High Similarity NPC110349
0.9349 High Similarity NPC148710
0.9341 High Similarity NPC476619
0.9341 High Similarity NPC476622
0.9341 High Similarity NPC476618
0.9341 High Similarity NPC476623
0.9341 High Similarity NPC476620
0.9341 High Similarity NPC476621
0.9337 High Similarity NPC198199
0.9333 High Similarity NPC137871
0.9333 High Similarity NPC256760
0.9333 High Similarity NPC117260
0.9333 High Similarity NPC180918
0.9333 High Similarity NPC172807
0.9333 High Similarity NPC254540
0.9333 High Similarity NPC257011
0.9333 High Similarity NPC211594
0.9333 High Similarity NPC288152
0.9333 High Similarity NPC476405
0.9333 High Similarity NPC9002
0.9333 High Similarity NPC261254
0.9329 High Similarity NPC86008
0.9325 High Similarity NPC115674
0.9325 High Similarity NPC99957
0.9325 High Similarity NPC181616
0.9325 High Similarity NPC210073
0.9321 High Similarity NPC88023
0.9321 High Similarity NPC127415
0.9321 High Similarity NPC309025
0.9321 High Similarity NPC29830
0.9321 High Similarity NPC243930
0.929 High Similarity NPC470447
0.929 High Similarity NPC470445
0.929 High Similarity NPC473072
0.929 High Similarity NPC470446
0.929 High Similarity NPC470449
0.9281 High Similarity NPC48984
0.9281 High Similarity NPC255799
0.9281 High Similarity NPC268533
0.9281 High Similarity NPC8573
0.9281 High Similarity NPC65563
0.9281 High Similarity NPC470949
0.9277 High Similarity NPC42773
0.9277 High Similarity NPC101026
0.9277 High Similarity NPC21666
0.9277 High Similarity NPC24043
0.9277 High Similarity NPC169977
0.9277 High Similarity NPC45522
0.9273 High Similarity NPC150767
0.9273 High Similarity NPC245014
0.9273 High Similarity NPC84265
0.9273 High Similarity NPC282987
0.9273 High Similarity NPC78734
0.9268 High Similarity NPC477502
0.9268 High Similarity NPC229729
0.9264 High Similarity NPC165720
0.9264 High Similarity NPC22832
0.9264 High Similarity NPC311830
0.9259 High Similarity NPC127782
0.9259 High Similarity NPC148273
0.9259 High Similarity NPC300537
0.9255 High Similarity NPC271270
0.9255 High Similarity NPC97285
0.9255 High Similarity NPC142860
0.9255 High Similarity NPC246469
0.9235 High Similarity NPC470451
0.9235 High Similarity NPC470455
0.9231 High Similarity NPC473071
0.9231 High Similarity NPC473073
0.9226 High Similarity NPC251417
0.9226 High Similarity NPC120952
0.9226 High Similarity NPC89052
0.9226 High Similarity NPC168584
0.9222 High Similarity NPC473327
0.9222 High Similarity NPC19108
0.9222 High Similarity NPC294815
0.9222 High Similarity NPC477848
0.9222 High Similarity NPC476472
0.9222 High Similarity NPC16194
0.9222 High Similarity NPC264735
0.9222 High Similarity NPC472607
0.9222 High Similarity NPC220173
0.9212 High Similarity NPC52382
0.9212 High Similarity NPC270578
0.9207 High Similarity NPC113093
0.9207 High Similarity NPC8856
0.9202 High Similarity NPC191306
0.9202 High Similarity NPC19709
0.9202 High Similarity NPC270335
0.9202 High Similarity NPC222936
0.9202 High Similarity NPC284960
0.9202 High Similarity NPC88043
0.9202 High Similarity NPC94777
0.9187 High Similarity NPC295613
0.9187 High Similarity NPC473657
0.9186 High Similarity NPC473618
0.9172 High Similarity NPC192539
0.9167 High Similarity NPC292019
0.9167 High Similarity NPC198324
0.9167 High Similarity NPC472385
0.9167 High Similarity NPC202908
0.9167 High Similarity NPC211532
0.9167 High Similarity NPC219043
0.9167 High Similarity NPC472991
0.9167 High Similarity NPC14187
0.9167 High Similarity NPC472992
0.9167 High Similarity NPC257714
0.9167 High Similarity NPC122467
0.9167 High Similarity NPC233994
0.9162 High Similarity NPC25724
0.9157 High Similarity NPC95866

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC293004 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.963 High Similarity NPD7074 Phase 3
0.9448 High Similarity NPD7054 Approved
0.939 High Similarity NPD7472 Approved
0.9222 High Similarity NPD7808 Phase 3
0.9162 High Similarity NPD7251 Discontinued
0.9107 High Similarity NPD4338 Clinical (unspecified phase)
0.9102 High Similarity NPD6797 Phase 2
0.9036 High Similarity NPD3818 Discontinued
0.8916 High Similarity NPD6167 Clinical (unspecified phase)
0.8916 High Similarity NPD6168 Clinical (unspecified phase)
0.8916 High Similarity NPD6166 Phase 2
0.8896 High Similarity NPD4381 Clinical (unspecified phase)
0.8869 High Similarity NPD7804 Clinical (unspecified phase)
0.8765 High Similarity NPD1934 Approved
0.8712 High Similarity NPD2801 Approved
0.8675 High Similarity NPD5494 Approved
0.8598 High Similarity NPD2393 Clinical (unspecified phase)
0.8545 High Similarity NPD3817 Phase 2
0.8383 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8303 Intermediate Similarity NPD4380 Phase 2
0.8286 Intermediate Similarity NPD6559 Discontinued
0.8274 Intermediate Similarity NPD3882 Suspended
0.8263 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8229 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8225 Intermediate Similarity NPD7075 Discontinued
0.8218 Intermediate Similarity NPD5844 Phase 1
0.8214 Intermediate Similarity NPD5402 Approved
0.8177 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.816 Intermediate Similarity NPD1511 Approved
0.8155 Intermediate Similarity NPD7819 Suspended
0.8061 Intermediate Similarity NPD1512 Approved
0.8057 Intermediate Similarity NPD7228 Approved
0.8035 Intermediate Similarity NPD3787 Discontinued
0.8012 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD7473 Discontinued
0.8 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7989 Intermediate Similarity NPD8313 Approved
0.7989 Intermediate Similarity NPD8312 Approved
0.7988 Intermediate Similarity NPD6801 Discontinued
0.7977 Intermediate Similarity NPD6959 Discontinued
0.7977 Intermediate Similarity NPD7199 Phase 2
0.7967 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7964 Intermediate Similarity NPD1653 Approved
0.7963 Intermediate Similarity NPD1549 Phase 2
0.7955 Intermediate Similarity NPD3751 Discontinued
0.795 Intermediate Similarity NPD2796 Approved
0.7941 Intermediate Similarity NPD1465 Phase 2
0.7939 Intermediate Similarity NPD6799 Approved
0.7931 Intermediate Similarity NPD6232 Discontinued
0.7929 Intermediate Similarity NPD7411 Suspended
0.7892 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7877 Intermediate Similarity NPD7240 Approved
0.7836 Intermediate Similarity NPD8455 Phase 2
0.7835 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7835 Intermediate Similarity NPD7783 Phase 2
0.7798 Intermediate Similarity NPD5403 Approved
0.7784 Intermediate Similarity NPD5401 Approved
0.7784 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD6779 Approved
0.7778 Intermediate Similarity NPD6777 Approved
0.7778 Intermediate Similarity NPD6776 Approved
0.7778 Intermediate Similarity NPD6778 Approved
0.7778 Intermediate Similarity NPD6781 Approved
0.7778 Intermediate Similarity NPD6782 Approved
0.7778 Intermediate Similarity NPD37 Approved
0.7778 Intermediate Similarity NPD7685 Pre-registration
0.7778 Intermediate Similarity NPD6780 Approved
0.7771 Intermediate Similarity NPD1247 Approved
0.7765 Intermediate Similarity NPD6599 Discontinued
0.7749 Intermediate Similarity NPD7696 Phase 3
0.7749 Intermediate Similarity NPD7435 Discontinued
0.7749 Intermediate Similarity NPD7697 Approved
0.7749 Intermediate Similarity NPD7698 Approved
0.7746 Intermediate Similarity NPD4966 Approved
0.7746 Intermediate Similarity NPD4967 Phase 2
0.7746 Intermediate Similarity NPD4965 Approved
0.7732 Intermediate Similarity NPD8151 Discontinued
0.7705 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7684 Intermediate Similarity NPD3926 Phase 2
0.768 Intermediate Similarity NPD7701 Phase 2
0.7679 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7669 Intermediate Similarity NPD1510 Phase 2
0.7657 Intermediate Similarity NPD6234 Discontinued
0.764 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7617 Intermediate Similarity NPD7871 Phase 2
0.7617 Intermediate Similarity NPD7870 Phase 2
0.7604 Intermediate Similarity NPD6823 Phase 2
0.7593 Intermediate Similarity NPD1933 Approved
0.7579 Intermediate Similarity NPD7700 Phase 2
0.7579 Intermediate Similarity NPD7699 Phase 2
0.7576 Intermediate Similarity NPD7266 Discontinued
0.7557 Intermediate Similarity NPD919 Approved
0.7538 Intermediate Similarity NPD7584 Approved
0.7531 Intermediate Similarity NPD1240 Approved
0.7531 Intermediate Similarity NPD1613 Approved
0.7531 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7513 Intermediate Similarity NPD6535 Approved
0.7513 Intermediate Similarity NPD7874 Approved
0.7513 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7513 Intermediate Similarity NPD6534 Approved
0.7475 Intermediate Similarity NPD7801 Approved
0.7443 Intermediate Similarity NPD7768 Phase 2
0.744 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD4628 Phase 3
0.7439 Intermediate Similarity NPD1607 Approved
0.7423 Intermediate Similarity NPD943 Approved
0.741 Intermediate Similarity NPD2935 Discontinued
0.7401 Intermediate Similarity NPD3749 Approved
0.7381 Intermediate Similarity NPD6674 Discontinued
0.7378 Intermediate Similarity NPD447 Suspended
0.7371 Intermediate Similarity NPD6844 Discontinued
0.7347 Intermediate Similarity NPD8319 Approved
0.7347 Intermediate Similarity NPD8320 Phase 1
0.7346 Intermediate Similarity NPD3027 Phase 3
0.7337 Intermediate Similarity NPD3750 Approved
0.7321 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD7458 Discontinued
0.7294 Intermediate Similarity NPD6190 Approved
0.7287 Intermediate Similarity NPD8434 Phase 2
0.7287 Intermediate Similarity NPD8150 Discontinued
0.7284 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD920 Approved
0.7278 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7277 Intermediate Similarity NPD6212 Phase 3
0.7277 Intermediate Similarity NPD6213 Phase 3
0.7277 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD230 Phase 1
0.7268 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD2534 Approved
0.7267 Intermediate Similarity NPD2532 Approved
0.7267 Intermediate Similarity NPD2533 Approved
0.7246 Intermediate Similarity NPD3748 Approved
0.7222 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD7680 Approved
0.7202 Intermediate Similarity NPD1551 Phase 2
0.72 Intermediate Similarity NPD3226 Approved
0.7191 Intermediate Similarity NPD5353 Approved
0.7186 Intermediate Similarity NPD7583 Approved
0.7178 Intermediate Similarity NPD6832 Phase 2
0.7176 Intermediate Similarity NPD2800 Approved
0.7168 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD2346 Discontinued
0.7151 Intermediate Similarity NPD5953 Discontinued
0.715 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.715 Intermediate Similarity NPD7585 Approved
0.7143 Intermediate Similarity NPD2799 Discontinued
0.7135 Intermediate Similarity NPD7286 Phase 2
0.7104 Intermediate Similarity NPD5242 Approved
0.7101 Intermediate Similarity NPD6100 Approved
0.7101 Intermediate Similarity NPD6099 Approved
0.7091 Intermediate Similarity NPD2313 Discontinued
0.7088 Intermediate Similarity NPD8127 Discontinued
0.7083 Intermediate Similarity NPD7097 Phase 1
0.7076 Intermediate Similarity NPD1243 Approved
0.7071 Intermediate Similarity NPD5005 Approved
0.7071 Intermediate Similarity NPD5006 Approved
0.7068 Intermediate Similarity NPD6842 Approved
0.7068 Intermediate Similarity NPD6843 Phase 3
0.7068 Intermediate Similarity NPD6841 Approved
0.7063 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD1091 Approved
0.7055 Intermediate Similarity NPD2798 Approved
0.7052 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD6233 Phase 2
0.7041 Intermediate Similarity NPD7033 Discontinued
0.7024 Intermediate Similarity NPD6651 Approved
0.7022 Intermediate Similarity NPD6386 Approved
0.7022 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7022 Intermediate Similarity NPD6385 Approved
0.7011 Intermediate Similarity NPD7390 Discontinued
0.6988 Remote Similarity NPD6798 Discontinued
0.6984 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6984 Remote Similarity NPD7549 Discontinued
0.6981 Remote Similarity NPD8059 Phase 3
0.6981 Remote Similarity NPD8058 Clinical (unspecified phase)
0.6977 Remote Similarity NPD1652 Phase 2
0.6974 Remote Similarity NPD4363 Phase 3
0.6974 Remote Similarity NPD4360 Phase 2
0.6973 Remote Similarity NPD7784 Clinical (unspecified phase)
0.697 Remote Similarity NPD4908 Phase 1
0.6965 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6964 Remote Similarity NPD6355 Discontinued
0.6964 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6959 Remote Similarity NPD2344 Approved
0.6957 Remote Similarity NPD7229 Phase 3
0.6954 Remote Similarity NPD4420 Approved
0.6941 Remote Similarity NPD651 Clinical (unspecified phase)
0.6936 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6919 Remote Similarity NPD2424 Discontinued
0.6919 Remote Similarity NPD5619 Clinical (unspecified phase)
0.691 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6909 Remote Similarity NPD9494 Approved
0.6886 Remote Similarity NPD4907 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data